C12N 2770/18041
Use of virus, viral particle or viral elements as a vector
C12N2770/18041 (Use of virus, viral particle or viral elements as a vector) appears on 4 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 10
- Assignees
- 6
- Inventors
- 23
- Latest grant
- 31 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 2 | 2 |
| 2025 | 0 | 3 |
By publication year.
Subgroups
Granted patents
- C12N 2770/18042Virus or viral particle as vehicleIndexing code3
- C12N 2770/18043Viral genome or elements thereof as genetic vectorIndexing code2
- C12N 2770/18044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2770/18045Special targeting system for viral vectorsIndexing code0
Recent patents
- Plant expression enhancer31 Dec 2024US 12,180,491 B2Aramis Biotechnologies Inc.
- Anti-cancer plant virus particles linked to HER2 antigens4 Jun 2024US 11,998,594 B2Case Western Reserve University
- Plant virus particles for delivery of photosensitive agents18 Feb 2020US 10,561,730 B2Case Western Reserve University
- Plant virus particles for delivery of photosensitive agents25 Dec 2018US 10,159,736 B2Case Western Reserve University
- Hydrogel formulations for vlp therapeutics3 Jul 2025US 2025/0213717 A1The Regents of the University of California
- One-step supramolecular multifunctional coating on plant virus nanoparticles for bioimaging and therapeutic applications12 Jun 2025US 2025/0186607 A1The Regents of the University of California
- Immune checkpoint targeting therapeutic nanoparticles24 Apr 2025US 2025/0127842 A1The Regents of the University of California
- Cancer prophylaxis and therapy using targeted viral nanoparticles27 Jun 2024US 2024/0209325 A1The Regents of the University of California
- Monovalent and multivalent vaccines for prevention and treatment of disease4 Apr 2024US 2024/0108716 A1The Regents of the University of California
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.